Research Articles | Page 24 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria Dec 2020 Blood, cells, molecules & diseases Paroxysmal Nocturnal Hemoglobinuria (PNH)
Following in the footsteps of acute myeloid leukemia: are we witnessing the start of a therapeutic revolution for higher-risk myelodysplastic syndromes? Oct 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Following in the footsteps of acute myeloid leukemia: are we witnessing the start of a therapeutic revolution for higher-risk myelodysplastic syndromes? Oct 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes Apr 2019 Blood Reviews Myelodysplastic Syndromes (MDS)
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? Nov 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria. Feb 2019 Cancer Med Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Exploring treatment strategies for paroxysmal nocturnal hemoglobinuria: an overview of registered clinical trials May 2024 Current Medical Research and Opinion Paroxysmal Nocturnal Hemoglobinuria (PNH)
Experience of life quality from patients with aplastic anemia: a descriptive qualitative study Dec 2023 Orphanet Journal of Rare Diseases Aplastic Anemia
Existing agents, novel agents, or transplantation for high-risk MDS Dec 2020 Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Evolving therapies for lower-risk myelodysplastic syndromes Apr 2020 Annals of Hematology Myelodysplastic Syndromes (MDS)